AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 32 filers reported holding AN2 THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $247,664 | +61.0% | 15,402 | -14.9% | 0.00% | – |
| Q2 2023 | $153,867 | -83.9% | 18,102 | -81.3% | 0.00% | – |
| Q1 2023 | $956,245 | -44.9% | 96,884 | -46.8% | 0.00% | – |
| Q4 2022 | $1,734,880 | +85.9% | 182,044 | +239.1% | 0.00% | – |
| Q3 2022 | $933,000 | +166.6% | 53,681 | +18.7% | 0.00% | – |
| Q2 2022 | $350,000 | – | 45,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 1,289,320 | $10,959,220 | 1.80% |
| Octagon Capital Advisors LP | 720,900 | $6,127,650 | 0.85% |
| RA Capital Management | 3,773,517 | $32,074,895 | 0.61% |
| BVF INC/IL | 1,563,963 | $13,293,686 | 0.37% |
| Monashee Investment Management LLC | 181,995 | $1,546,958 | 0.37% |
| Avidity Partners Management LP | 657,200 | $5,586,200 | 0.20% |
| Y-Intercept (Hong Kong) Ltd | 14,040 | $119,340 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 27,500 | $233,750 | 0.01% |
| Alyeska Investment Group, L.P. | 98,426 | $836,621 | 0.01% |
| JANUS HENDERSON GROUP PLC | 1,000,068 | $8,590,578 | 0.01% |